Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels.

Skylar-Scott MA, Uzel SGM, Nam LL, Ahrens JH, Truby RL, Damaraju S, Lewis JA.

Sci Adv. 2019 Sep 6;5(9):eaaw2459. doi: 10.1126/sciadv.aaw2459. eCollection 2019 Sep.

2.

Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.

Anoveros-Barrera A, Bhullar AS, Stretch C, Esfandiari N, Dunichand-Hoedl AR, Martins KJB, Bigam D, Khadaroo RG, McMullen T, Bathe OF, Damaraju S, Skipworth RJ, Putman CT, Baracos VE, Mazurak VC.

J Cachexia Sarcopenia Muscle. 2019 Jul 15. doi: 10.1002/jcsm.12466. [Epub ahead of print]

3.

Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.

Kumaran M, Ghosh S, Joy AA, Mackey JR, Cass CE, Zheng W, Yasui Y, Damaraju S.

Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32407. [Epub ahead of print]

PMID:
31087647
4.

Oncogenic activity of poly (ADP-ribose) glycohydrolase.

Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M.

Oncogene. 2019 Mar;38(12):2177-2191. doi: 10.1038/s41388-018-0568-6. Epub 2018 Nov 20.

5.

Single-Nucleotide Polymorphisms in TAOK3 Are Associated With High Opioid Requirement for Pain Management in Patients With Advanced Cancer Admitted to a Tertiary Palliative Care Unit.

Gutteridge T, Kumaran M, Ghosh S, Fainsinger R, Klepstad P, Tarumi Y, Damaraju S, Baracos VE.

J Pain Symptom Manage. 2018 Oct;56(4):560-566. doi: 10.1016/j.jpainsymman.2018.07.011. Epub 2018 Jul 20.

PMID:
30031856
6.

The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics.

Krishnan P, Damaraju S.

Int J Genomics. 2018 Apr 30;2018:5848046. doi: 10.1155/2018/5848046. eCollection 2018. Review.

7.

Breast cancer associated germline structural variants harboring small noncoding RNAs impact post-transcriptional gene regulation.

Kumaran M, Krishnan P, Cass CE, Hubaux R, Lam W, Yasui Y, Damaraju S.

Sci Rep. 2018 May 14;8(1):7529. doi: 10.1038/s41598-018-25801-1.

8.

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.

Stretch C, Aubin JM, Mickiewicz B, Leugner D, Al-Manasra T, Tobola E, Salazar S, Sutherland FR, Ball CG, Dixon E, Vogel HJ, Damaraju S, Baracos VE, Bathe OF.

PLoS One. 2018 May 3;13(5):e0196235. doi: 10.1371/journal.pone.0196235. eCollection 2018.

9.

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

Fernandes R, Mazzarello S, Joy AA, Pond GR, Hilton J, Ibrahim MFK, Canil C, Ong M, Stober C, Vandermeer L, Hutton B, da Costa M, Damaraju S, Clemons M.

Support Care Cancer. 2018 Sep;26(9):3073-3081. doi: 10.1007/s00520-018-4161-x. Epub 2018 Mar 21.

PMID:
29564623
10.

Cardiac sarcoidosis presenting as arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular aneurysms: a case report.

Petrovic M, Buja LM, Kar B, Colnaric J, Damaraju S, Zhao B, Akkanti B, Radovanovic M, Radovancevic R, Loyalka P, Gregoric ID.

Cardiovasc Pathol. 2018 Mar - Apr;33:1-5. doi: 10.1016/j.carpath.2017.11.001. Epub 2017 Nov 10.

PMID:
29245138
11.

Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models.

VanderSluis L, Mazurak VC, Damaraju S, Field CJ.

Int J Mol Sci. 2017 Dec 4;18(12). pii: E2607. doi: 10.3390/ijms18122607. Review.

12.

Germline copy number variations are associated with breast cancer risk and prognosis.

Kumaran M, Cass CE, Graham K, Mackey JR, Hubaux R, Lam W, Yasui Y, Damaraju S.

Sci Rep. 2017 Nov 7;7(1):14621. doi: 10.1038/s41598-017-14799-7.

13.

Three-dimensional piezoelectric fibrous scaffolds selectively promote mesenchymal stem cell differentiation.

Damaraju SM, Shen Y, Elele E, Khusid B, Eshghinejad A, Li J, Jaffe M, Arinzeh TL.

Biomaterials. 2017 Dec;149:51-62. doi: 10.1016/j.biomaterials.2017.09.024. Epub 2017 Sep 19.

PMID:
28992510
14.

Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia.

Narasimhan A, Greiner R, Bathe OF, Baracos V, Damaraju S.

J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):60-70. doi: 10.1002/jcsm.12235. Epub 2017 Oct 6.

15.

High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.

Gupta N, Jung K, Wu C, Alshareef A, Alqahtani H, Damaraju S, Mackey JR, Ghosh S, Sabri S, Abdulkarim BS, Bigras G, Lai R.

Oncotarget. 2017 Apr 25;8(17):28101-28115. doi: 10.18632/oncotarget.15891.

16.

Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.

Narasimhan A, Ghosh S, Stretch C, Greiner R, Bathe OF, Baracos V, Damaraju S.

J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):405-416. doi: 10.1002/jcsm.12168. Epub 2017 Jan 6.

17.

New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.

Johns N, Stretch C, Tan BH, Solheim TS, Sørhaug S, Stephens NA, Gioulbasanis I, Skipworth RJ, Deans DA, Vigano A, Ross JA, Bathe OF, Tremblay ML, Kaasa S, Strasser F, Gagnon B, Baracos VE, Damaraju S, Fearon KC.

J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):122-130. doi: 10.1002/jcsm.12138. Epub 2016 Aug 5.

18.

Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2.

Saad A, Bijian K, Qiu D, da Silva SD, Marques M, Chang CH, Nassour H, Ramotar D, Damaraju S, Mackey J, Bismar T, Witcher M, Alaoui-Jamali MA.

Sci Rep. 2016 Nov 7;6:36699. doi: 10.1038/srep36699.

19.

A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility.

Sapkota Y, Narasimhan A, Kumaran M, Sehrawat BS, Damaraju S.

Cytogenet Genome Res. 2016;149(3):156-164. Epub 2016 Sep 27.

20.

Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer.

Krishnan P, Ghosh S, Graham K, Mackey JR, Kovalchuk O, Damaraju S.

Oncotarget. 2016 Jun 21;7(25):37944-37956. doi: 10.18632/oncotarget.9272.

21.

Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.

Krishnan P, Ghosh S, Wang B, Heyns M, Graham K, Mackey JR, Kovalchuk O, Damaraju S.

PLoS One. 2016 Sep 15;11(9):e0162622. doi: 10.1371/journal.pone.0162622. eCollection 2016.

22.

Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer.

Krishnan P, Ghosh S, Wang B, Heyns M, Li D, Mackey JR, Kovalchuk O, Damaraju S.

Sci Rep. 2016 Sep 8;6:32843. doi: 10.1038/srep32843.

23.

The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.

Pandya V, Glubrecht D, Vos L, Hanson J, Damaraju S, Mackey J, Hugh J, Goping IS.

Oncotarget. 2016 May 31;7(22):33272-85. doi: 10.18632/oncotarget.8924.

24.

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

Sawyer MB, Pituskin E, Damaraju S, Bies RR, Vos LJ, Prado CM, Kuzma M, Scarfe AG, Clemons M, Tonkin K, Au HJ, Koski S, Joy AA, Smylie M, King K, Carandang D, Damaraju VL, Hanson J, Cass CE, Mackey JR.

Clin Breast Cancer. 2016 Apr;16(2):139-44.e1-3. doi: 10.1016/j.clbc.2015.09.006. Epub 2015 Sep 25.

PMID:
26452313
25.

Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.

Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, Graham K, Mackey JR, Kovalchuk O, Damaraju S.

BMC Genomics. 2015 Sep 29;16:735. doi: 10.1186/s12864-015-1899-0.

26.

Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells.

St George M, Ayoub AT, Banerjee A, Churchill CD, Winter P, Klobukowski M, Cass CE, Ludueña RF, Tuszynski JA, Damaraju S.

PLoS One. 2015 Jun 8;10(6):e0129168. doi: 10.1371/journal.pone.0129168. eCollection 2015.

27.

The role of gap junctions and mechanical loading on mineral formation in a collagen-I scaffold seeded with osteoprogenitor cells.

Damaraju S, Matyas JR, Rancourt DE, Duncan NA.

Tissue Eng Part A. 2015 May;21(9-10):1720-32. doi: 10.1089/ten.TEA.2014.0522. Epub 2015 Mar 31.

28.

Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies.

Johns N, Tan BH, MacMillan M, Solheim TS, Ross JA, Baracos VE, Damaraju S, Fearon KC.

J Genet. 2014 Dec;93(3):893-916. Review.

29.

A practical tool for modeling biospecimen user fees.

Matzke L, Dee S, Bartlett J, Damaraju S, Graham K, Johnston R, Mes-Masson AM, Murphy L, Shepherd L, Schacter B, Watson PH.

Biopreserv Biobank. 2014 Aug;12(4):234-9. doi: 10.1089/bio.2014.0008.

PMID:
25162459
30.

The effect of mechanical stimulation on mineralization in differentiating osteoblasts in collagen-I scaffolds.

Damaraju S, Matyas JR, Rancourt DE, Duncan NA.

Tissue Eng Part A. 2014 Dec;20(23-24):3142-53. doi: 10.1089/ten.TEA.2014.0026.

31.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

Le Page C, Köbel M, de Ladurantaye M, Rahimi K, Madore J, Babinszky S, Bachvarov DR, Bachvarova M, Beauchamp MC, Cass CE, Chadwick D, Colleen C, Damaraju S, Dufour J, Gotlieb WH, Kalloger SE, Portelance L, McAlpine JN, Matte I, Piché A, Shaw P, Roehrl MH, Vanderhyden BC, Watson PH, Huntsman DG, Provencher DM, Mes-Masson AM.

Biopreserv Biobank. 2013 Apr;11(2):83-93. doi: 10.1089/bio.2012.0044. Erratum in: Biopreserv Biobank. 2013 Aug;11(4):257. Roehrl, Michael H A [added].

PMID:
24845429
32.

Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience.

Barnes R, Albert M, Damaraju S, de Sousa-Hitzler J, Kodeeswaran S, Mes-Masson AM, Watson P, Schacter B.

Biopreserv Biobank. 2013 Dec;11(6):387-96. doi: 10.1089/bio.2013.0061. Epub 2013 Nov 22.

PMID:
24835369
33.

Breast cancer prediction using genome wide single nucleotide polymorphism data.

Hajiloo M, Damavandi B, Hooshsadat M, Sangi F, Mackey JR, Cass CE, Greiner R, Damaraju S.

BMC Bioinformatics. 2013;14 Suppl 13:S3. doi: 10.1186/1471-2105-14-S13-S3. Epub 2013 Oct 1.

34.

Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification.

Tang Y, Mackey J, Lai R, Ghosh S, Santos C, Graham K, Damaraju S, Pasdar M, Li L.

J Proteomics. 2013 Oct 8;91:200-9. doi: 10.1016/j.jprot.2013.06.034. Epub 2013 Jul 11.

PMID:
23851309
35.

Structural changes in PVDF fibers due to electrospinning and its effect on biological function.

Damaraju SM, Wu S, Jaffe M, Arinzeh TL.

Biomed Mater. 2013 Aug;8(4):045007. doi: 10.1088/1748-6041/8/4/045007. Epub 2013 Jun 17.

PMID:
23770816
36.

Effects of sample size on differential gene expression, rank order and prediction accuracy of a gene signature.

Stretch C, Khan S, Asgarian N, Eisner R, Vaisipour S, Damaraju S, Graham K, Bathe OF, Steed H, Greiner R, Baracos VE.

PLoS One. 2013 Jun 3;8(6):e65380. doi: 10.1371/journal.pone.0065380. Print 2013.

37.

Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.

Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, Robson PJ, Kopciuk K, Cass CE, Yasui Y, Damaraju S.

PLoS One. 2013 Jun 3;8(6):e64896. doi: 10.1371/journal.pone.0064896. Print 2014.

38.

Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm.

Sapkota Y, Yasui Y, Lai R, Sridharan M, Robson PJ, Cass CE, Mackey JR, Damaraju S.

PLoS One. 2013 May 22;8(5):e62550. doi: 10.1371/journal.pone.0062550. Print 2013.

39.

ETHNOPRED: a novel machine learning method for accurate continental and sub-continental ancestry identification and population stratification correction.

Hajiloo M, Sapkota Y, Mackey JR, Robson P, Greiner R, Damaraju S.

BMC Bioinformatics. 2013 Feb 22;14:61. doi: 10.1186/1471-2105-14-61.

40.

Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.

Sapkota Y, Ghosh S, Lai R, Coe BP, Cass CE, Yasui Y, Mackey JR, Damaraju S.

PLoS One. 2013;8(1):e53850. doi: 10.1371/journal.pone.0053850. Epub 2013 Jan 16.

41.

Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).

Matzke EA, O'Donoghue S, Barnes RO, Daudt H, Cheah S, Suggitt A, Bartlett J, Damaraju S, Johnston R, Murphy L, Shepherd L, Mes-Masson AM, Schacter B, Watson PH.

Biopreserv Biobank. 2012 Oct;10(5):426-32. doi: 10.1089/bio.2012.0026.

PMID:
24845043
42.

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Anglesio MS, Kommoss S, Tolcher MC, Clarke B, Galletta L, Porter H, Damaraju S, Fereday S, Winterhoff BJ, Kalloger SE, Senz J, Yang W, Steed H, Allo G, Ferguson S, Shaw P, Teoman A, Garcia JJ, Schoolmeester JK, Bakkum-Gamez J, Tinker AV, Bowtell DD, Huntsman DG, Gilks CB, McAlpine JN.

J Pathol. 2013 Jan;229(1):111-20. doi: 10.1002/path.4088.

PMID:
22899400
43.

Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia.

Craddock TJ, St George M, Freedman H, Barakat KH, Damaraju S, Hameroff S, Tuszynski JA.

PLoS One. 2012;7(6):e37251. doi: 10.1371/journal.pone.0037251. Epub 2012 Jun 25.

44.

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.

Hurvitz SA, Betting DJ, Stern HM, Quinaux E, Stinson J, Seshagiri S, Zhao Y, Buyse M, Mackey J, Driga A, Damaraju S, Sliwkowski MX, Robert NJ, Valero V, Crown J, Falkson C, Brufsky A, Pienkowski T, Eiermann W, Martin M, Bee V, Marathe O, Slamon DJ, Timmerman JM.

Clin Cancer Res. 2012 Jun 15;18(12):3478-86. doi: 10.1158/1078-0432.CCR-11-2294. Epub 2012 Apr 13.

45.

The clonal and mutational evolution spectrum of primary triple-negative breast cancers.

Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, Griffith M, Moradian A, Cheng SW, Morin GB, Watson P, Gelmon K, Chia S, Chin SF, Curtis C, Rueda OM, Pharoah PD, Damaraju S, Mackey J, Hoon K, Harkins T, Tadigotla V, Sigaroudinia M, Gascard P, Tlsty T, Costello JF, Meyer IM, Eaves CJ, Wasserman WW, Jones S, Huntsman D, Hirst M, Caldas C, Marra MA, Aparicio S.

Nature. 2012 Apr 4;486(7403):395-9. doi: 10.1038/nature10933.

46.

P-selectin genotype is associated with the development of cancer cachexia.

Tan BH, Fladvad T, Braun TP, Vigano A, Strasser F, Deans DA, Skipworth RJ, Solheim TS, Damaraju S, Ross JA, Kaasa S, Marks DL, Baracos VE, Skorpen F, Fearon KC; European Palliative Care Research Collaborative.

EMBO Mol Med. 2012 Jun;4(6):462-71. doi: 10.1002/emmm.201200231. Epub 2012 Apr 4.

47.

A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.

Sapkota Y, Robson P, Lai R, Cass CE, Mackey JR, Damaraju S.

Eur J Hum Genet. 2012 Jun;20(6):682-9. doi: 10.1038/ejhg.2011.273. Epub 2012 Jan 18.

48.

Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach.

Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R, Baracos VE.

J Nutr. 2012 Jan;142(1):14-21. doi: 10.3945/jn.111.147751. Epub 2011 Dec 7.

PMID:
22157537
49.

Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.

Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, Graham K, Khan S, Damaraju S, Colmers WF, Baracos VE, Marks DL.

J Exp Med. 2011 Nov 21;208(12):2449-63. doi: 10.1084/jem.20111020. Epub 2011 Nov 14.

50.

Functions of the water soluble chlorophyll-binding protein in plants.

Damaraju S, Schlede S, Eckhardt U, Lokstein H, Grimm B.

J Plant Physiol. 2011 Aug 15;168(12):1444-51. doi: 10.1016/j.jplph.2011.02.007. Epub 2011 Apr 9.

PMID:
21481489

Supplemental Content

Loading ...
Support Center